Proteasome Inhibitor Bortezomib Modulates TLR4-induced Dendritic Cell Activation

Blood - United States
doi 10.1182/blood-2005-08-3494
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Society of Hematology

Related search

Chloroquine Modulates HIV-1-Induced Plasmacytoid Dendritic Cell Alpha Interferon: Implication for T-Cell Activation

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2009English

Ameliorating Effects of Bortezomib, a Proteasome Inhibitor, on Development of Dextran Sulfate Sodium-Induced Murine Colitis

Journal of Clinical Biochemistry and Nutrition
MedicineNutritionClinical BiochemistryDietetics
2018English

P27Kip1in Proteasome Inhibitor-Induced Apoptosis

Cell Cycle
MedicineDevelopmental BiologyCell BiologyMolecular Biology
2003English

Alterations of the Intracellular Peptidome in Response to the Proteasome Inhibitor Bortezomib

PLoS ONE
Multidisciplinary
2013English

The Combination of MBP and BCG-Induced Dendritic Cell Maturation Through TLR2/TLR4 Promotes Th1 Activation in Vitro and Vivo

Mediators of Inflammation
ImmunologyCell Biology
2017English

The Proteasome Inhibitor Bortezomib Enhances ATRA-Induced Differentiation of Neuroblastoma Cells via the JNK Mitogen-Activated Protein Kinase Pathway

PLoS ONE
Multidisciplinary
2011English

Sensitizing Human Multiple Myeloma Cells to the Proteasome Inhibitor Bortezomib by Novel Curcumin Analogs

International Journal of Molecular Medicine
MedicineGenetics
2011English

The Role of SP-D in Dendritic Cell Induced T-Cell Activation

Journal of Allergy and Clinical Immunology
AllergyImmunology
2019English

Proteasome Inhibitor, Bortezomib, Potently Inhibits the Growth of Adult T-Cell Leukemia Cells Both in Vivo and in Vitro

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2004English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy